Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

NCT ID: NCT01879774

Last Updated: 2022-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

189 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2022-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this epidemiological study is to characterize the neuropsychological and motoric performance in patients with hyponatremia. Newer studies revealed an association between mild hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the paradigm of an "asymptomatic" hyponatremia. Until now, there is no known detailed investigation and characterisation of the cognitive and motoric performance or limitation by this disorder. Therefore this study will investigate patients with hyponatremia on the basis of neuropsychological and neurological tests.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized patients. The prevalence of hospital-associated hyponatremia is estimated to be up to 40%. Especially mild to moderate hyponatremia (125-136 mmo/l) without apparent symptoms has seldomly been accurately assessed but rather seen as clinically irrelevant. Cognitive limitations, unstable gait and motoric disorders as well as depressive conditions were described in smaller studies and single case reports.

In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic hyponatremia it is necessary to establish an accurate phenotyping of patients with hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.

Patients with hyponatremia will be examined on the basis of standardized neuropsychological and neurological tests. Following questions are to be answered with this study:

1. Which cognitive, motoric and psychological functions are impaired due to hyponatremia?
2. Is there a correlation between the extend of hyponatremia and the different test results?
3. Is there an intraindividual difference in test results during hyponatremia and normal sodium concentrations?

In addition to clinical testing, functional magnetic resonance imaging (fMRI) will be performed before and after therapy in up to 40 patients with hyponatremia. Functional magnetic resonance imaging (fMRI) is an imaging procedure in which local changes in cerebral oxygen concentration can be used to draw conclusions about brain activity. In connection with the current research project, an initial contribution is to be made in order to close the existing knowledge gap as to whether a functionally-image-morphologically tangible change in cerebral activity can also be depicted non-invasively by means of fMRI during hyponatremia or after its compensation. Another component of cerebral evaluation in this context is volumetry in fMRI.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyponatremia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with hyponatremia

Neuropsychological and motoric tests are conducted in patients with hyponatremia.

Group Type OTHER

Neuropsychological and motoric tests

Intervention Type OTHER

1. Neuropsychological tests

* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests

* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)

Patients with normal serum sodium

Neuropsychological and motoric tests are conducted in patients with normal serum sodium.

Group Type OTHER

Neuropsychological and motoric tests

Intervention Type OTHER

1. Neuropsychological tests

* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests

* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuropsychological and motoric tests

1. Neuropsychological tests

* Mini Mental Status Test
* Dem-Tect
* Rey-Osterrieth Complex Figure Test
* Trailmaking Test
* Beck Depression Inventory
* d2-R (optional)
2. Motoric tests

* modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
* Timed-up-and-go Test
* Halstead Fingertapping Test
* AIMS (Abnormal involuntary movement scale)
3. EEG (only in patients with hyponatremia)
4. MRI (only in patients with hyponatremia)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 18 years of age or older
* Hyponatremia with serum sodium \< 130 mmol/l
* Men and women with normal serum sodium \> 130 mmol/l (control group)

Exclusion Criteria

* traumatic cerebral injury, hemorrhagic and ischemic insult as cause of hyponatremia
* professional or private relationship between subject and the investigators, or dependance on the investigators
* Placement in an institution based on official orders
* Patients who are unable to give informed consent
* Patients with contraindication for MRI investigation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Cologne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Volker Burst

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Volker Burst, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Cologne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Cologne

Cologne, , Germany

Site Status

Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Mario Serio

Florence, , Italy

Site Status

Hospital Universitario Clinico San Carlos

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Italy Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.